George Matcham

Director/Board Member at INSTIL BIO, INC.

Net worth: 275 844 $ as of 30/09/2026

74 year

Health Technology

Consumer Services

Profile

George Matcham is currently an Independent Director at Instil Bio, Inc. since 2018.
Formerly, Dr. Matcham was a Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) from 2021 to 2023.
From 2017 to 2018, Dr. Matcham was SVP-CAR T CMC & Technology Development at Celgene Corp.
Dr. Matcham also served as Chief Operating Officer at Celgene Cellular Therapeutics.
Education includes graduate studies at the University of Cambridge and undergraduate and doctorate degrees from the University of Cardiff.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INSTIL BIO, INC. 0.56%	11/06/2026	38,100 ( 0.56% )	275 844 $	30/09/2026

George Matcham active positions

Companies	Position	Start
INSTIL BIO, INC.	Director/Board Member	01/09/2018

All active positions of George Matcham

Former positions of George Matcham

Companies	Position	End
CHIMERIC THERAPEUTICS LIMITED	Director/Board Member	03/08/2023
CELGENE	Corporate Officer/Principal	01/06/2018
Celgene Cellular Therapeutics Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals	Chief Operating Officer	-

See the detail of George Matcham's experience

Education of George Matcham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of George Matcham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cardiff University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Celgene Cellular Therapeutics Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals	Health Technology
Instil Bio, Inc. Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer	Health Technology
Chimeric Therapeutics Ltd. (Australia) Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors	Health Technology